Abstract

Bioluminescence imaging (BLI) is an optical imaging method that can be translated from the cell culture dish in vitro to cell tracking in small animal models in vivo. In contrast to the more widely used fluorescence imaging, which requires light excitation, in BLI the light is exclusively generated by the enzyme luciferase. The luciferase gene can be engineered to target and monitor almost every cell and biological process quantitatively in vitro and even from deep tissue in vivo. While initially used for tumor imaging, bioluminescence was recently optimized for mouse brain imaging of neural cells and monitoring of viability or differentiation of grafted stem cells. Here, we describe the use of bright color-shifted firefly luciferases (Flucs) based on the thermostable x5 Fluc that emit red and green for effective and quantitative unmixing of two human cell populations in vitro and after transplantation into the mouse brain in vivo. Spectral unmixing predicts the ratio of luciferases in vitro and a mixture of cells precisely for cortical grafts, however, with less accuracy for striatal grafts. This dual-color approach enables the simultaneous visualization and quantification of two cell populations on the whole brain scale, with particular relevance for translational studies of neurological disorders providing information on stem cell survival and differentiation in one imaging session in vivo.

Highlights

  • Luciferases (Flucs) are very efficient molecular and biochemical tools to track cells and proteins and to monitor gene expression in living organisms.[1]

  • The dual-color Firefly luciferases (Flucs) pair x5g/r was tested against the bioluminescence spectra of WT Fluc

  • We further showed that the spectral unmixing for CBG99 and PpyRE9 was possible for deep tissue grafts, with limitation to qualitative analysis.[25]

Read more

Summary

Introduction

Luciferases (Flucs) are very efficient molecular and biochemical tools to track cells and proteins and to monitor gene expression in living organisms.[1] While the first bioluminescence imaging (BLI) was limited to tumor applications,[2] the firefly gene and the detection hardware were continuously optimized to monitor other cell types, such as stem cells and neurons, in deep tissue with higher or equal sensitivity and specificity compared to, for example, fluorescence imaging.[3,4,5,6,7,8] BLI has some unique advantages such as the light is produced directly in the Fluc-expressing cells without the need of an excitation source, promoting a very low background and high signal-tonoise ratios. Multicolor BLI, the simultaneous imaging of two or more luciferases with distinct emission spectra, emerged first for in vitro assays and later for imaging bacteria or tumor cells in vivo.[13,14,15,16] Spectral

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call